• Email:
  • Password:
  • Remember Me
 
Lecture Hall General Diabetes | Treatment

CGM in Type 1 Diabetes: Knowledge Leads to Better Results

Available Credits
CME 0.75
CDR 1

William Tamborlane
William Tamborlane, MD, FAAP, FACE
Director of the Childrens Diabetes Program
Yale Pediatrics
Yale School of Medicine
New Haven, CT
System Requirements Method of Participation Disclosure Information

This lecture by Dr. William Tamborlane, MD describes the potential benefits of real-time continuous glucose monitoring (RT-CGM) in the management of patients with type 1 diabetes (T1D). It reviews the evidence from randomized clinical trials that has been incorporated into the American Diabetes Association guidelines for use of these devices in clinical practice. Recent studies have also demonstrated improved outcomes when CGM is combined with insulin pump therapy in patients who are unable to achieve target A1c levels with glargine-based multiple daily injection regimens.

Goal and Objective
After participating in this activity, the viewer should be better able to:
1. To know how real time continuous glucose monitoring (RT-CGM) can be utilized to improve basal/bolus insulin therapy in type 1 diabetes (T1D).
2. To recognize that A1c levels can be reduced with RT-CGM in adults and in selected children with T1D in whom A1c levels are elevated, if they utilize the devices on a nearly daily basis.
3. To know that RT-CGM can also benefit patients with T1D who have A1c levels < 7.0% by helping them to maintain target A1c levels with reduced biochemical hypoglycemia.
4. To know how patients perceive the benefits and hassles of using current CGM devices.
5. To be aware that improved control of diabetes can be achieved by the nearly simultaneous introduction of CGM combined with insulin pump therapy in patients who are unable to achieve target A1c levels with glargine-based multiple daily injection regimen

Estimated time to complete this activity is 47 minutes.

Physicians, diabetes educators, and other health care professionals who treat patients with diabetes.
Accreditation and Designation of Credit
MEDICINE: The Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Mount Sinai School of Medicine designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 06/15/2011 Expiration Date: 06/15/2012
Peer Review: on 08/17/2010

DIETITIAN: PRESENT e-Learning Systems is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered Dietitians (RDs) and Registered Dietetic Technicians (DTRs) will receive 1 continuing professional education units (CPEUs) for completion of this program/material.

Release Date: 08/31/2010 Expiration Date: 02/19/2014
Peer Review: on 08/17/2010

System Requirements
CGM in Type 1 Diabetes: Knowledge Leads to Better Results
Top
A Pentium-III class computer with a minimum of 256MB of system RAM is required to view Online Internet lectures. While a 56Kbps dial-up connection is supported, a Cable or DSL broadband Internet is strongly recommended for optimal video playback. You will need an up-to-date web browser such as Internet Explorer, Mozilla Firefox, or the AOL browser with Java and JavaScript enabled. Some lectures require the use of Internet Explorer to run and will not run with other browsers. Lectures may require the use of helper applications or plug-ins to access the materials. For example, most online lectures/presentations require either Adobe Flash Player or Windows Media Player (both free). To be able to print completion certificates Adobe Acrobat Reader must be installed.
Method of Participation
CGM in Type 1 Diabetes: Knowledge Leads to Better Results
Top
Complete the 4 steps to earn CE/CME credit:
  • Complete and submit the required pre-test
  • View Lecture
  • Complete and submit post-test and program evaluation. Credit will be issued with a passing score of 70% or better.
  • Click Print Certificate.
Disclosure Information
CGM in Type 1 Diabetes: Knowledge Leads to Better Results
Top
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.
William Tamborlane, MD, FAAP, FACE William V Tamborlane, MD has disclosed that he has received Honorarium/Expenses from Medtronic Diabetes